Contemporary Concepts in Prostate Cancer is an online resource for professionals within the oncology space, from medical oncologists and pathologists to oncology nurses and mental health experts. Prostate cancer is the most common cancers in men within the United States beyond skin cancer, and is most likely to develop in older and non–Hispanic Black men. Due to this, CancerNetwork® has created a central hub to inform oncology professionals about the latest non-clinical developments in patient care. Contemporary Concepts in Prostate Cancer also provides the most recent findings regarding patient-specific issues such as the psychosocial impact of prostate cancer, sexual health, disparities in care and outcomes, survivorship and quality of life, and financial toxicity.
Contemporary Concepts in Prostate Cancer showcases articles, podcasts, and video interviews with key opinion leaders in the field to keep you up to date with the latest developments in the prostate oncology space.
July 26 2023, 4:00pm
Flotufolastat F 18 is indicated for use in imaging PSMA-positive prostate cancer lesions in patients who are likely to have metastatic disease and may be able to undergo initial definitive therapy, as well as those who may have recurrent disease.
October 20 2022, 6:00pm
A meta-analysis found Black men who undergo radiotherapy for localized prostate cancer have better outcomes in terms of biochemical recurrence, distant metastases, and prostate cancer-specific mortality than White men despite presenting with more aggressive disease.
September 2 2022, 4:00pm
Findings from a study revealed a notable reduction in the risk of prostate cancer–specific mortality in Black United States veterans who underwent prostate-specific antigen screening, highlighting the potential importance of undergoing annual screenings in this patient population.
August 31 2022, 2:00pm
Investigators highlighted that when determining a treatment strategy for patients with early-stage prostate cancer, baseline benign prostate hyperplasia symptoms should be taken into consideration.
February 24 2022, 5:00pm
A health-related quality of life assessment found an association between worsened self-reported fatigue, cognitive function, and physical function, with enzalutamide treatment for patients with metastatic, hormone-sensitive prostate cancer but improved deterioration-free survival for overall health and quality of life.
January 14 2022, 7:00pm
Despite presenting with high-risk disease, Black patients with prostate cancer who enrolled on radiation therapy clinical trials were reported to have better rates of biochemical recurrence, distant metastases, and prostate cancer–specific mortality than White patients.
December 3 2021, 7:00pm
The National Comprehensive Cancer Network has reversed its previous ruling in September and instead recommends patients with low-risk prostate cancer receive active surveillance.
November 12 2021, 9:00pm
PSA testing rates for prostate cancer increased among men after the US Preventive Services Task Force released updated guidance in 2017 that reversed the recommendations from previous guidance in 2012.